Medpace Holdings (MEDP) analyst forecast and price target
Analyst forecast
Consensus of 15 analyst ratings
Based on 7 analyst targets
Recent analyst ratings
| Firm | Action | Rating | Price target | Date |
|---|---|---|---|---|
| Baird | Maintained | Neutral | $624.00 from $547.00 | Jul 24, 2026 |
| RBC Capital | Maintained | Outperform | $692.00 from $484.00 | Jul 24, 2026 |
| TD Cowen | Maintained | Hold | $492.00 from $419.00 | Jul 24, 2026 |
| Truist Securities | Maintained | Hold | $609.00 from $462.00 | Jul 24, 2026 |
| BMO Capital | Maintained | Market Perform | $600.00 from $400.00 | Jul 24, 2026 |
| Mizuho | Maintained | Outperform | $665.00 from $586.00 | Jul 24, 2026 |
| Mizuho | Maintained | Outperform | $586.00 from $495.00 | Jul 13, 2026 |
| Baird | Downgraded | Outperform → Neutral | $547.00 from $477.00 | Jul 8, 2026 |
| Jefferies | Downgraded | Buy → Hold | $515.00 from $490.00 | Jul 7, 2026 |
| Baird | Maintained | Outperform | $477.00 from $565.00 | Apr 24, 2026 |
| RBC Capital | Maintained | Outperform | $484.00 from $522.00 | Apr 24, 2026 |
| BMO Capital | Maintained | Market Perform | $400.00 from $460.00 | Apr 24, 2026 |
| Barclays | Maintained | Equal-Weight | $450.00 from $500.00 | Apr 24, 2026 |
| Barclays | Upgraded | Underweight → Equal-Weight | $500.00 | Mar 6, 2026 |
| RBC Capital | Initiated Coverage | Outperform | $522.00 | Mar 3, 2026 |
| TD Cowen | Upgraded | Sell → Hold | $419.00 from $462.00 | Feb 18, 2026 |
| Jefferies | Upgraded | Hold → Buy | $560.00 | Feb 13, 2026 |
| Leerink Partners | Maintained | Market Perform | $485.00 from $575.00 | Feb 11, 2026 |
| Truist Securities | Maintained | Hold | $539.00 from $555.00 | Feb 11, 2026 |
| Barclays | Maintained | Underweight | $500.00 from $525.00 | Feb 11, 2026 |
Frequently asked questions
What is the price target for MEDP stock?
The average 12-month analyst price target for Medpace Holdings (MEDP) is $599.57, with a high estimate of $692.00 and a low of $492.00, across 7 analysts.
Is MEDP a buy, sell, or hold?
Analysts covering Medpace Holdings currently average a Hold rating: 2 buy, 11 hold and 2 sell, from 15 analysts. Ratings reflect analyst opinion, not investment advice.
What upside do analysts see for MEDP?
The average price target of $599.57 implies 1.17% upside from the last price of $592.65.
What is the latest analyst rating on MEDP?
On Jul 24, 2026, Baird maintained Medpace Holdings at Neutral with a price target of $624.00.
Analyst ratings and price targets are the opinions of third-party research firms, not of Light Horse Securities. They are estimates about an uncertain future, are frequently wrong, and are neither a recommendation nor a prediction of actual results.
This page is for informational purposes only. Nothing on it is a recommendation, solicitation or offer to buy or sell any security, nor investment, legal or tax advice. Light Horse Securities Inc does not verify third-party data and is not responsible for its accuracy, completeness or timeliness.